Back to top
more

Inspire Medical Systems (INSP)

(Delayed Data from NYSE)

$249.72 USD

249.72
354,939

-1.47 (-0.59%)

Updated May 3, 2024 04:00 PM ET

After-Market: $249.93 +0.21 (0.08%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

1-Strong Buy of 5 1        

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value A Growth D Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 40% (100 out of 252)

Industry: Medical Info Systems

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Why Inspire Medical (INSP) Might Surprise This Earnings Season

by Zacks Equity Research

Inspire Medical (INSP) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Inspire Medical Systems (INSP) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release

by Zacks Equity Research

Inspire (INSP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Inspire Medical Systems (INSP) Reports Q3 Loss, Tops Revenue Estimates

by Zacks Equity Research

Inspire (INSP) delivered earnings and revenue surprises of 37.70% and 10.90%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate Inspire Medical Systems (INSP) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

Inspire (INSP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Industry Outlook Highlights: 10x Genomics, Omnicell, Inspire Medical Systems and Cerner

by Zacks Equity Research

Zacks Industry Outlook Highlights: 10x Genomics, Omnicell, Inspire Medical Systems and Cerner

Urmimala Biswas headshot

Buy 3 Medical Info Systems Stocks to Brave Industry-wide Challenges

by Urmimala Biswas

Stocks like 10x Genomics Inc. (TXG), Omnicell, Inc. (OMCL) and Inspire Medical Systems, Inc. (INSP) are expected to gain despite pandemic-led disruptions.

Inspire Medical Systems (INSP) Reports Q2 Loss, Tops Revenue Estimates

by Zacks Equity Research

Inspire (INSP) delivered earnings and revenue surprises of 21.31% and 17.95%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Will Inspire Medical Systems (INSP) Report Negative Earnings Next Week? What You Should Know

by Zacks Equity Research

Inspire (INSP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Inspire Medical Systems (INSP) Reports Q1 Loss, Tops Revenue Estimates

by Zacks Equity Research

Inspire (INSP) delivered earnings and revenue surprises of 7.69% and 9.18%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

Inspire Medical Systems (INSP) Reports Q4 Loss, Tops Revenue Estimates

by Zacks Equity Research

Inspire (INSP) delivered earnings and revenue surprises of 37.78% and 10.18%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

NextGen (NXGN) Solution Acts as Financial Bridge Amid COVID-19

by Zacks Equity Research

NextGen's (NXGN) cloud-based EHR platform, NextGen Office, enables specialty practices to improve their financial performance during the pandemic.

    Should First Trust Mid Cap Growth AlphaDEX ETF (FNY) Be on Your Investing Radar?

    by Zacks Equity Research

    Style Box ETF report for FNY

    Should First Trust Mid Cap Growth AlphaDEX ETF (FNY) Be on Your Investing Radar?

    by Zacks Equity Research

    Style Box ETF report for FNY

    Should First Trust Mid Cap Growth AlphaDEX ETF (FNY) Be on Your Investing Radar?

    by Zacks Equity Research

    Style Box ETF report for FNY

    Inspire Medical Systems (INSP) Reports Q3 Loss, Tops Revenue Estimates

    by Zacks Equity Research

    Inspire (INSP) delivered earnings and revenue surprises of 45.07% and 59.33%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

    Urmimala Biswas headshot

    Medical Products Earnings Due on Nov 2: STE, HSIC & More

    by Urmimala Biswas

    Several medical product stocks have come up with bullish earnings reports so far this reporting cycle. Let's see how STE, HSIC, PACB, INSP are poised ahead of their announcements.

    Analysts Estimate Inspire Medical Systems (INSP) to Report a Decline in Earnings: What to Look Out for

    by Zacks Equity Research

    Inspire (INSP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

    Inspire Medical Systems (INSP) Reports Q2 Loss, Tops Revenue Estimates

    by Zacks Equity Research

    Inspire (INSP) delivered earnings and revenue surprises of 18.52% and 39.71%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

    Earnings Preview: Inspire Medical Systems (INSP) Q2 Earnings Expected to Decline

    by Zacks Equity Research

    Inspire (INSP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

    Inspire Medical Systems (INSP) Reports Q1 Loss, Tops Revenue Estimates

    by Zacks Equity Research

    Inspire (INSP) delivered earnings and revenue surprises of -17.54% and 0.03%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

    Is a Surprise Coming for Inspire Medical (INSP) This Earnings Season?

    by Zacks Equity Research

    Inspire Medical (INSP) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

    Inspire Medical Systems (INSP) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

    by Zacks Equity Research

    Inspire (INSP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

    Why Inspire Medical Systems (INSP) Stock Might be a Great Pick

    by Zacks Equity Research

    Inspire Medical Systems (INSP) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.

    Inspire Medical Systems (INSP) Reports Q4 Loss, Tops Revenue Estimates

    by Zacks Equity Research

    Inspire (INSP) delivered earnings and revenue surprises of 9.52% and 12.62%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

    Why Inspire Medical Systems (INSP) Might Surprise This Earnings Season

    by Zacks Equity Research

    Inspire (INSP) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.